Shareholding disclosure

Cytos Biotechnology AG

Declared position

99.27%

Threshold

Crossed downwards

Timeline

Published

24.05.2012

Transaction

18.05.2012

Voting rights breakdown

Voting rights acquired11.87%
Voting rights sold99.27%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAC5N00028

Beneficial owner

Cytos Biotechnology AG

Declared address

Cytos Biotechnology AG, 8952 Schlieren

Datum der Entstehung der Meldepflicht (Veröffentlichung der Kapitalerhöhung im Schweizerischen Handelsamtsblatt) Veränderung des Gesellschaftskapitals: Kapitalerhöhung

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open